Mucormycosis is a clinical syndrome associated with infection by molds called mucormycetes. During the COVID-19 pandemic, it has come to prominence as a secondary infection, especially in India. The general epidemiology, clinical features, investigations and treatment of mucormycosis will be explored, as will the epidemiology of invasive fungal infections during COVID-19.
About the speaker
Sanjaya Senanayake is an Infectious Diseases Physician in Canberra, Australia. He is an Associate Professor of Medicine at the Australian National University and Director of the Department of Infectious Diseases at Canberra Health Services. Dr Senanayake has a strong interest in infections of public health importance. He has been a regular presence in the media during the pandemic.